“…Nonetheless, there are important differences between humans and mice that affect the potential of these latter to serve as models for HL in man [ 86 ]; they present a shorter lifespan that may preclude them from appropriately modelling the late onset and progressive HL recorded in many patients, as well as a lack of genetic heterogeneity that is in stark contrast to that found in human populations [ 1 , 87 ]; they also differ in the time that is required for their inner ears to fully develop and in the amino acid sequence of important proteins [ 88 ]. Moreover, there are mouse lines that, despite carrying genetic mutations identical to some found in patients, do not exhibit the same symptoms [ 9 , 10 , 87 ]; in this regard, differences in gene expression patterns between primates and rodents have been associated with a failure of some of the murine models to recapitulate the human disease [ 9 , 21 , 24 , 25 , 26 ]. The common marmoset, also amenable to genetic modification, has thus been proposed as a more predictive model of human cochlear development and pathology [ 21 , 22 ].…”